Pharmarama International Limited relaunches as Alium Medical
pharmafile | September 22, 2014 | News story | |
Pharmarama International Ltd, one of the leading specialist in pharmaceutical services, has relaunched under the new brand name Alium Medical Limited. This is the final piece of the jigsaw to realign the brand following the appointment of Nadia Whittley as CEO in January this year.
The brand, Alium Medical, has been created to represent the new company strategy and the new phase the company has entered at the beginning of this year. Mrs Whittley commented, “Alium Medical is a much more contemporary brand that will have greater resonance amongst our target market. We feel it better reflects our image and personality and that is more representative of the new portfolio of services and products that we offer. Alium Medical will position us uniquely, and will support strongly our differentiation strategy in the marketplace”
Nadia Whittley was appointed at the beginning of this year to identify and implement a new growth strategy and set a vision for the future. Together with a renewed senior management team, she has redefined the company core areas and introduced a new clinical and commercial focus. “Alium Medical’s ambitious plans will continue to leverage the company’s experience in clinical trial comparator sourcing, introducing new ways to overcome the challenges pharmaceutical companies face when planning and running a clinical study. Our renewed clinical and commercial teams will offer a new channel to market for many new products, whether licensed or unlicensed, creating a unique opportunity for our partners and their patients.”
Whether a healthcare provider looking for unlicensed or licensed treatment options, a pharmaceutical company looking to introduce an unlicensed product through a Managed Access Program (MAP) or commercialise a licensed product (Product Lifecycle Management), Alium Medical prides itself by finding the solution to make this possible.
